Recruiting nowPhase 2Ages 65 Years and up
A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Sponsor: Institut Claudius Regaud · NCT06022159 on ClinicalTrials.gov ↗
Conditions studied
Soft Tissue Sarcoma
What it tests
- Hypofractionated Radiation Therapyradiation
- Conservative treatmentprocedure
Where it's running11 sites
11 international sites
- Recruiting now
Institut Bergonie
Bordeaux, France
- Pauline GILLON(contact)05 56 33 33 43[email protected]
- Recruiting now
Centre Oscar Lambret
Lille, France
- Abel CORDOBA LARGO(contact)03 20 29 59 59[email protected]
- Recruiting now
Chu de Limoges
Limoges, France
- Hélène ORLIAC(contact)05 55 05 62 68[email protected]
- Recruiting now
Centre Leon Berard
Lyon, France
- Waisse WAISSI(contact)04 78 78 28 28[email protected]
- Recruiting now
Institut Regional Du Cancer de Montpellier
Montpellier, France
- Carmen LLACER-MOSCARDO(contact)04 67 61 37 79[email protected]
- Recruiting now
Institut Curie
Paris, France
- Sylvie HELFRE(contact)01 44 32 46 25[email protected]
- Recruiting now
Chu de Poitiers
Poitiers, France
- Sarah GARCIA MOLINA(contact)05 49 44 44 44[email protected]
- Recruiting now
Institut de Cancerologie de L'Ouest
Saint-Herblain, France
- Augustin MERVOYER(contact)02 40 67 99 00[email protected]
- Recruiting now
Chu de Toulouse
Toulouse, France
- Louis COURTOT(contact)05 61 77 21 04[email protected]
- Recruiting now
IUCT-O
Toulouse, France
- Justine ATTAL KHALIFA(contact)05 31 15 54 38[email protected]
- Recruiting now
Institut Gustave Roussy
Villejuif, France
- Cécile LE PECHOUX(contact)01 42 11 42 11[email protected]
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: 1. Patient with histologically confirmed soft tissue sarcoma of the limbs or trunk. 2. Indication for neo-adjuvant or adjuvant radiotherapy. 3. Patient aged ≥ 70 years with a performance status ECOG ≤ 2 and/or aged 65 to 70 years with an ECOG of 2 and identified by the investigator as "fragile". 4. Patient affiliated to a Social Health Insurance in France. 5. Patient able to participate and willing to give informed consent prior performance of any study-related procedures. Exclusion Criteria: 1. Retroperitoneal, ORL and visceral sarcomas. 2. Previous radiotherapy in the area. 3. Metastatic disease. 4. Concomitant or sequential chemotherapy. 5. Patient requiring total surgery (amputation). 6. Other cancer under treatment. 7. Any condition or pathology contraindicating MRI. 8. Any psychological, familial, geographic or social situation, potentially preventing the provision of informed consent or compliance to study procedure. 9. Patients included in another therapeutic interventional trial. 10. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Updated 2026-06-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.